Last reviewed · How we verify

NCT05715086: UPURS

UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones

Recruiting now NA Last updated 17 January 2025
What this trial tests

NA trial testing Ureteroscopy in Ureteral Stone in 100 participants. Currently enrolling.

Timeline
23 August 2023
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date23 August 2023
Primary completion30 June 2026
Estimated completion30 June 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

18 and older, any sex, with Ureteral Stone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, non-blinded, randomized controlled trial studying the management of symptomatic ureteral stones. This study will compare upfront ureteroscopy vs observation and delayed intervention for patients presenting to the emergency department with a symptomatic ureteral stone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ureteroscopy

Trials testing the same drug.

Other recruiting trials for Ureteral Stone

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05715086.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing